17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

244. Berkowitz RS, Cramer DW, Bernstein<br />

MR, Cassells S, Driscoll SG, Goldstein DP<br />

(1985). Risk factors for complete molar<br />

pregnancy from a case-control study. Am<br />

J Obstet Gynecol 152: 1016-1020.<br />

245. Berkowitz RS, Ehrmann RL, Knapp RC<br />

(1978). Endometrial stromal sarcoma arising<br />

from vaginal endometriosis. O b s t e t<br />

Gynecol 51: 34s-37s.<br />

246. Berliant II (1970). [Neurofibroma of the<br />

broad ligament of the uterus]. A k u s h<br />

Ginekol (Mosk) 46: 70-71.<br />

247. Berman ML, Soper JT, Creasman WT,<br />

Olt GT, Disaia PJ (1989). Conservative surgical<br />

management of superficially invasive<br />

stage I vulvar <strong>carcinoma</strong>. Gynecol Oncol<br />

35: 352-357.<br />

248. Bermudez A, Vighi S, Garcia A, Sardi J<br />

(2001). Neuroendocrine cervical <strong>carcinoma</strong>:<br />

a diagnostic and therapeutic challenge.<br />

Gynecol Oncol 82: 32-39.<br />

249. Berns EM, Foekens JA, Vossen R,<br />

Look MP, Devilee P, Henzen-Logmans SC,<br />

van Staveren IL, van Putten WL, Inganas<br />

M, Meijer-van Gelder ME, Cornelisse C,<br />

Claassen CJ, Portengen H, Bakker B, Klijn<br />

JG (2000). Complete sequencing of TP53<br />

predicts poor response to systemic therapy<br />

of advanced <strong>breast</strong> cancer. Cancer Res<br />

60: 2155-2162.<br />

250. Berns EM, Klijn JG, van Putten WL,<br />

van Staveren IL, Portengen H, Foekens JA<br />

(1992). c-myc amplification is a better<br />

prognostic factor than HER2/neu amplification<br />

in primary <strong>breast</strong> cancer. Cancer<br />

Res 52: 1107-1113.<br />

251. Berns EM, van Staveren IL, Look MP,<br />

Smid M, Klijn JG, Foekens JA (1998).<br />

Mutations in residues of TP53 that directly<br />

contact DNA predict poor outcome in<br />

human primary <strong>breast</strong> cancer. Br J Cancer<br />

77: 1130-1136.<br />

252. Bernstein JL, Thompson WD, Risch N,<br />

Holford TR (1992). Risk factors predicting<br />

the incidence of second primary <strong>breast</strong><br />

cancer among women diagnosed with a<br />

first primary <strong>breast</strong> cancer. Am J<br />

Epidemiol 136: 925-936.<br />

253. Bernstein JL, Thompson WD, Risch N,<br />

Holford TR (1992). The genetic epidemiolo -<br />

gy of second primary <strong>breast</strong> cancer. Am J<br />

Epidemiol 136: 937-948.<br />

254. Bernstein L, Deapen D, Ross RK (1993).<br />

The descriptive epidemiology of malignant<br />

cystosarcoma phyllodes tumors of the<br />

<strong>breast</strong>. Cancer 71: 3020-3024.<br />

255. Bernstein L, Ross RK (1993).<br />

Endogenous hormones and <strong>breast</strong> cancer<br />

risk. Epidemiol Rev 15: 48-65.<br />

256. Berrino F, Capocaccia R, Esteve J,<br />

Gatta G, Hakulinen T, Micheli A, Sant M,<br />

Verdecchia A (1999). Survival of Cancer<br />

patients in Europe: The EUROCARE-2<br />

Study. <strong>IARC</strong> Scientific Publication No 151.<br />

International Agency for Research on<br />

Cancer: Lyon.<br />

257. Bertucci F, Nasser V, Granjeaud S,<br />

Eisinger F, Adelaide J, Tagett R, Loriod B,<br />

Giaconia A, Benziane A, Devilard E,<br />

Jacquemier J, Viens P, Nguyen C,<br />

Birnbaum D, Houlgatte R (2002). Gene<br />

expression profiles of poor-prognosis primary<br />

<strong>breast</strong> cancer correlate with survival.<br />

Hum Mol Genet 11: 863-872.<br />

258. Bertwistle D, Swift S, Marston NJ,<br />

Jackson LE, Crossland S, Crompton MR,<br />

Marshall CJ, Ashworth A (1997). Nuclear<br />

location and cell cycle regulation of the<br />

BRCA2 protein. Cancer Res 57: 5485-5488.<br />

259. Berx G, Becker KF, Hofler H, van Roy F<br />

(1998). Mutations of the human E-cadherin<br />

(CDH1) gene. Hum Mutat 12: 226-237.<br />

260. Berx G, Cleton-Jansen AM, Nollet F,<br />

de Leeuw WJ, van de Vijvert M, Cornelisse<br />

C, van Roy F (1995). E-cadherin is a<br />

tumour/invasion suppressor gene mutated<br />

in human lobular <strong>breast</strong> cancers. EMBO J<br />

14: 6107-6115.<br />

261. Berx G, Cleton-Jansen AM, Strumane<br />

K, de Leeuw WJ, Nollet F, van Roy F,<br />

Cornelisse C (1996). E-cadherin is inactivated<br />

in a majority of invasive human lobular<br />

<strong>breast</strong> cancers by truncation mutations<br />

throughout its extracellular domain.<br />

Oncogene 13: 1919-1925.<br />

262. Bethwaite PB, Holloway LJ, Yeong<br />

ML, Thornton A (1993). Effect of tumour<br />

associated tissue eosinophilia on survival<br />

of women with stage IB <strong>carcinoma</strong> of the<br />

uterine cervix. J Clin Pathol 46: 1016-1020.<br />

263. Bethwaite PB, Koreth J, Herrington<br />

CS, McGee JO (1995). Loss of heterozygosity<br />

occurs at the D11S29 locus on chromosome<br />

11q23 in invasive cervical <strong>carcinoma</strong>.<br />

Br J Cancer 71: 814-818.<br />

264. Biankin SA, O’Toole VE, Fung C,<br />

Russell P (2000). Bizarre leimyoma of the<br />

vagina: Report of a case. Int J Gynecol<br />

Pathol 19: 186-187.<br />

265. Bieche I, Lidereau R (1995). Genetic<br />

alterations in <strong>breast</strong> cancer. G e n e s<br />

Chromosomes Cancer 14: 227-251.<br />

266. Bieche I, Lidereau R (1999). Increased<br />

level of exon 12 alternatively spliced<br />

BRCA2 transcripts in tumor <strong>breast</strong> tissue<br />

compared with normal tissue. Cancer Res<br />

59: 2546-2550.<br />

267. Bieche I, Nogues C, Lidereau R (1999).<br />

Overexpression of BRCA2 gene in sporadic<br />

<strong>breast</strong> tumours. Oncogene 18: 5232-5238.<br />

268. Bienenstock J, Befus AD (1980).<br />

Mucosal immunology. Immunology 41: 249-<br />

270.<br />

269. Biernat W, Jablkowski W (2000).<br />

Syringomatous adenoma of the nipple. Pol<br />

J Pathol 51: 201-202.<br />

270. Bijker N, Peterse JL, Duchateau L,<br />

Robanus-Maandag EC, Bosch CA, Duval C,<br />

Pilotti S, Van de Vijver MJ (2001).<br />

Histological type and marker expression of<br />

the primary tumour compared with its local<br />

recurrence after <strong>breast</strong>-conserving therapy<br />

for ductal <strong>carcinoma</strong> in situ. Br J<br />

Cancer 84: 539-544.<br />

271. Bijker N, Rutgers EJ, Peterse JL,<br />

Fentiman IS, Julien JP, Duchateau L, van<br />

Dongen JA (2001). Variations in diagnostic<br />

and therapeutic procedures in a multicentre,<br />

randomized clinical trial (EORTC 10853)<br />

investigating <strong>breast</strong>-conserving treatment<br />

for DCIS. Eur J Surg Oncol 27: 135-140.<br />

272. Bingham C, Roberts D, Hamilton TC<br />

(2001). The role of molecular biology in<br />

understanding ovarian cancer initiation<br />

and progression. Int J Gynecol Cancer 11<br />

Suppl 1: 7-11.<br />

273. Birch JM, Hartley AL, Blair V, Kelsey<br />

AM, Harris M, Teare MD, Jones PH (1990).<br />

Cancer in the families of children with soft<br />

tissue sarcoma. Cancer 66: 2239-2248.<br />

274. Birkeland SA, Storm HH, Lamm LU,<br />

Barlow L, Blohme I, Forsberg B, Eklund B,<br />

Fjeldborg O, Friedberg M, Frodin L, Glattre<br />

E, Halvorsen S, Holm NV, Jakobsen A,<br />

Jorgensen HE, Ladefoged J, Lindholm T,<br />

Lundgren G, Pukkala E. (1995). Cancer risk<br />

after renal transplantation in the Nordic<br />

countries, 1964-1986. Int J Cancer 60: 183-<br />

189.<br />

275. Bisceglia M, Attino V, D'Addetta C,<br />

Murgo R, Fletcher CD (1996). [Early stage<br />

Stewart-Treves syndrome: report of 2<br />

cases and review of the literature].<br />

Pathologica 88: 483-490.<br />

276. Bisceglia M, Fusilli S, Zaffarano L,<br />

Fiorentino F, Tardio B (1995). [Inflammatory<br />

pseudotumor of the <strong>breast</strong>. Report of a<br />

case and review of the literature].<br />

Pathologica 87: 59-64.<br />

277. Biscotti CV, Hart WR (1989). Juvenile<br />

granulosa cell tumors of the ovary. Arch<br />

Pathol Lab Med 113: 40-46.<br />

278. Biscotti CV, Hart WR (1992). Peritoneal<br />

serous micropapillomatosis of low malignant<br />

potential (serous borderline tumors of<br />

the peritoneum). A clinicopathologic study<br />

of 17 cases. Am J Surg Pathol 16: 467-475.<br />

279. Biscotti CV, Hart WR (1998). Apoptotic<br />

bodies: a consistent morphologic feature<br />

of endocervical adeno<strong>carcinoma</strong> in situ.<br />

Am J Surg Pathol 22: 434-439.<br />

2 8 0 . Bishara M, Scapa E (1997). [Stromal<br />

uterine sarcoma arising from intestinal<br />

endometriosis after abdominal hysterectomy<br />

and salpingo-oophorectomy]. H a r e f u a h<br />

133: 353-355.<br />

281. Bishop DT, Hopper J (1997). AT-tributable<br />

risks? Nat Genet 15: 226.<br />

2 8 2 . Bitterman P, Chun B, Kurman RJ<br />

(1990). The significance of epithelial differentiation<br />

in mixed mesodermal tumors of<br />

the uterus. A clinicopathologic and<br />

immunohistochemical study. Am J Surg<br />

Pathol 14: 317-328.<br />

283. Bjorkholm E, Silfversward C (1980).<br />

Theca-cell tumors. Clinical features and<br />

prognosis. Acta Radiol Oncol 19: 241-244.<br />

284. Bjorkholm E, Silfversward C (1981).<br />

Prognostic factors in granulosa-cell<br />

tumors. Gynecol Oncol 11: 261-274.<br />

285. Black CL, Morris DM, Goldman LI,<br />

McDonald JC (1983). The significance of<br />

lymph node involvement in patients with<br />

medullary <strong>carcinoma</strong> of the <strong>breast</strong>. Surg<br />

Gynecol Obstet 157: 497-499.<br />

286. Black MM, Barclay TH, Hankey BF<br />

(1975). Prognosis in <strong>breast</strong> cancer utilizing<br />

histologic characteristics of the primary<br />

tumor. Cancer 36: 2048-2055.<br />

287. Blaker H, Graf M, Rieker RJ, Otto HF<br />

(1999). Comparison of losses of heterozygosity<br />

and replication errors in primary<br />

colorectal <strong>carcinoma</strong>s and corresponding<br />

liver metastases. J Pathol 188: 258-262.<br />

288. Blamey RW (1998). Clinical aspects of<br />

malignant <strong>breast</strong> lesions In: Systemic<br />

Pathology, CW Elston, IO Ellis (Eds.). 3rd<br />

ed. Churchill Livingstone: Edinburgh, pp.<br />

501-513.<br />

289. Bloch T, Roth LM, Stehman FB, Hull<br />

MT, Schwenk GR Jr. (1988). Osteosarcoma<br />

of the uterine cervix associated with<br />

hyperplastic and atypical mesonephric<br />

rests. Cancer 62: 1594-1600.<br />

290. Block E (1947). Squamous cell <strong>carcinoma</strong><br />

of the fallopian tube. Acta Radiol 28:<br />

49-68.<br />

291. Blom R, Guerrieri C, Stal O, Malmstrom<br />

H, Simonsen E (1998). Leiomyosarcoma of<br />

the uterus: A clinicopathologic, DNA flow<br />

cytometric, p53, and mdm-2 analysis of 49<br />

cases. Gynecol Oncol 68: 54-61.<br />

292. Blom R, Malmstrom H, Guerrieri C<br />

(1999). Endometrial stromal sarcoma of the<br />

uterus: a clinicopathologic, DNA flow cytometric,<br />

p53, and mdm-2 analysis of 17<br />

cases. Int J Gynecol Cancer 9: 98-104.<br />

293. Bloom HJ, Richardson WW (1957).<br />

Histological grading and prognosis in<br />

<strong>breast</strong> cancer. Br J Cancer 11: 359-377.<br />

294. Bloom HJ, Richardson WW, Field JR<br />

(1970). Host resistance and survival in car -<br />

cinoma of <strong>breast</strong>: a study of 104 cases of<br />

medullary <strong>carcinoma</strong> in a series of 1,411<br />

cases of <strong>breast</strong> cancer followed for 20<br />

years. Br Med J 3: 181-188.<br />

295. Boardman CH, Webb MJ, Jefferies JA<br />

(2000). Low-grade endometrial stromal sarcoma<br />

of the ectocervix after therapy for<br />

<strong>breast</strong> cancer. Gynecol Oncol 79: 120-123.<br />

296. Bobrow LG, Richards MA, Happerfield<br />

LC, Diss TC, Isaacson PG, Lammie GA,<br />

Millis RR (1993). Breast lymphomas: a clin -<br />

icopathologic review. Hum Pathol 24: 274-<br />

278.<br />

297. Bochar DA, Wang L, Beniya H, Kinev<br />

A, Xue Y, Lane WS, Wang W, Kashanchi F,<br />

Shiekhattar R (2000). BRCA1 is associated<br />

with a human SWI/SNF-related complex:<br />

linking chromatin remodeling to <strong>breast</strong><br />

cancer. Cell 102: 257-265.<br />

298. Bodian CA, Perzin KH, Lattes R (1996).<br />

Lobular neoplasia. Long term risk of <strong>breast</strong><br />

cancer and relation to other factors.<br />

Cancer 78: 1024-1034.<br />

2 9 9 . Bodian CA, Perzin KH, Lattes R,<br />

Hoffmann P, Abernathy TG (1993).<br />

Prognostic significance of benign proliferative<br />

<strong>breast</strong> disease. Cancer 71: 3896-3907.<br />

300. Bodner K, Bodner-Adler B, Obermair<br />

A, Windbichler G, Petru E, Mayerhofer S,<br />

Czerwenka K, Leodolter S, Kainz C,<br />

Mayerhofer K (2001). Prognostic parameters<br />

in endometrial stromal sarcoma: a<br />

clinicopathologic study in 31 patients.<br />

Gynecol Oncol 81: 160-165.<br />

301. Boecker W, Buerger H, Schmitz K, Ellis<br />

IA, van Diest PJ, Sinn H-P, Geradts J,<br />

Diallo R, Poremba C, Herbst H (2001).<br />

Ductal epithelial proliferations of the<br />

<strong>breast</strong>: a biological continuum? Comparative<br />

genomic hybridization an highmolecular-weight<br />

cytokeratin expression<br />

patterns. J Pathol 195: 415-421.<br />

302. Bohm J, Roder-Weber M, Hofler H,<br />

Kolben M (1991). Bilateral stromal Leydig<br />

cell tumour of the ovary. Case report and<br />

literature review. Pathol Res Pract 187:<br />

348-352.<br />

303. Boice JD Jr., Engholm G, Kleinerman<br />

RA, Blettner M, Stovall M, Lisco H,<br />

Moloney WC, Austin DF, Bosch A, Cookfair<br />

DL, Krementz ET, Latourettte HB, Merrill<br />

JA, Peters LJ, Schultz MD, Strom HH,<br />

Bjorkholm E, Pettersson F, Bell CMJ,<br />

Coleman MP, Fraser P, Neal FE, Prior P,<br />

Choi NW, Hislop TG, Koch M, Kreiger N,<br />

Robb D, Robson D, Thomson DH,<br />

Lochmuller H, Vonfournier D, Frischkorn R,<br />

Kjorstad KE, Rimpela A, Pejovic MH, Kirn<br />

VP, Stankusova H, Berrino F, Sigurdsson K,<br />

Hutchinson GB, Macmahon B (1988).<br />

Radiation dose and second cancer risk in<br />

patients treated for cancer of the cervix.<br />

Radiat Res 116: 3-55.<br />

304. Boice JD Jr., Preston D, Davis FG,<br />

Monson RR (1991). Frequent chest X-ray<br />

fluoroscopy and <strong>breast</strong> cancer incidence<br />

among tuberculosis patients in<br />

Massachusetts. Radiat Res 125: 214-222.<br />

305. Boks D.E., Trujillo A.P., Voogd AC,<br />

Morreau H, Kenter GG, Vasen HF (2002).<br />

Survival analysis of endometrial <strong>carcinoma</strong><br />

asociated with hereditary nonpolyposis<br />

colorectal cancer. Int J Cancer 102: 198-<br />

200.<br />

306. Boland CR, Thibodeau SN, Hamilton<br />

SR, Sidransky D, Eshleman JR, Burt RW,<br />

Meltzer SJ, Rodriguez-Bigas MA, Fodde R,<br />

Ranzani GN, Srivastava S (1998). A<br />

National Cancer Institute Workshop on<br />

Microsatellite Instability for cancer detection<br />

and familial predisposition: development<br />

of international criteria for the deter -<br />

mination of microsatellite instability in<br />

colorectal cancer. Cancer Res 58: 5248-<br />

5257.<br />

376 References

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!